期刊
CLINICAL INFECTIOUS DISEASES
卷 69, 期 11, 页码 2011-2014出版社
OXFORD UNIV PRESS INC
DOI: 10.1093/cid/ciz223
关键词
gram-negative bacteremia; treatment duration; Pseudomonas aeruginosa; piperacillin-tazobactam; cefepime
资金
- US Food and Drug Administration (FDA) [HHSF223201610070C]
In a multicenter, observational, propensity-score-weighted cohort of 249 adults with uncomplicated Pseudomonas aeruginosa bacteremia, patients receiving short-course (median, 9 days; interquartile range [IQR], 8-10) therapy had a similar odds of recurrent infection or death within 30 days as those receiving longer courses (median, 16 days; IQR, 14-17).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据
分享论文
